Back to Search
LISA FORCE, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1376818476IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
ML 60292766(WA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD60573226(WA)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2012
Research & Publications (20)
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
PMID 19214120·J Acquir Immune Defic Syndr·2009
4-observational
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
PMID 19663689·Clin Infect Dis·2009
4-observational
Functional status as a risk factor for mortality in very elderly patients with pneumonia.
PMID 18674485·Med Clin (Barc)·2008
8-other
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
PMID 18297762·J Acquir Immune Defic Syndr·2008
8-other
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.
PMID 17255745·AIDS·2007
2-rct
Sporadic and epidemic community legionellosis: two faces of the same illness.
PMID 17005576·Eur Respir J·2007
4-observational
Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.
PMID 16856621·Antivir Ther·2006
4-observational
Poor response to hepatitis C virus (HCV) therapy in HIV- and HCV-coinfected patients is not due to lower adherence to treatment.
PMID 16706615·AIDS Res Hum Retroviruses·2006
3-trial
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
PMID 16623634·AIDS Res Hum Retroviruses·2006
4-observational
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.
PMID 16312180·Antivir Ther·2005
3-trial
[Validation of a questionnaire to estimate satisfaction with antiretroviral treatment: CESTA questionnaire].
PMID 16324547·Enferm Infecc Microbiol Clin·2005
4-observational
[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project].
PMID 15847748·Med Clin (Barc)·2005
8-other
A measure of subjective burden for dementia care: the Caregiving Difficulty Scale--Intellectual Disability.
PMID 15817053·J Intellect Disabil Res·2005
8-other
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.
PMID 15385735·J Acquir Immune Defic Syndr·2004
3-trial
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
PMID 12968087·N Engl J Med·2003
3-trial
New fluorescence parameters for monitoring photosynthesis in plants.
PMID 16245061·Photosynth Res·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4800 SAND POINT WAY NE # A-5950
SEATTLE, WA 98105 - Phone
- (206) 987-2525
Quick Facts
- NPI
- 1376818476
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile